Remove Ethics Remove Fixed Costs Remove Price Remove Tactics
article thumbnail

Solving the $100,000 Cancer Drug Problem

Harvard Business Review

Last week over 100 leading cancer specialists signed their names to an op-ed in Blood , the journal of the American Society of Hematology, which lambasted the prices of cancer drugs that often exceed $100,000 annually. While pharma companies spend billions on research, the actual cost of manufacturing a treatment (such as a pill) is minimal.

article thumbnail

Why Tesco’s Strengths Are No Longer Good Enough

Harvard Business Review

Successful companies are notoriously prone to pursuing tactical fixes rather than confronting strategic problems. They exhort their people to try harder, introduce overhead cost reduction programs, and reorganize – anything rather than admit that their strategy needs an overhaul. Aldi offers not just low prices, but convenience.

Retail 9